Related Experiment Video
Updated: Aug 12, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
Control of E2F activity by p21Waf1/Cip1
1Division of Biochemistry and Molecular Biology, Davidson Building, University of Glasgow, Glasgow, G12 8QQ, UK.
Abstract:
Cyclin-dependent kinase inhibitors (cdkis), such as p21, are believed to control proliferation through an ability to function as stoichiometric antagonists of cyclin-dependent kinases (cdks). The p21 gene is a direct transcriptional target for the p53 protein, and its activation is likely to be important in effecting the p53 response. It is widely accepted that p21 can influence cell cycle progression by controlling the activity of cdks that act on the retinoblastoma tumour suppressor protein (pRb) which, in a hypophosphorylated state, associates with E2F transcription factors to prevent the activation of genes required for progression into S phase. Phosphorylation of pRb by G1 cdk complexes releases E2F and thereby enables progress through the cell cycle. Here, we describe results which suggest a p21-dependent mechanism that facilitates the regulation of E2F through a pathway that is independent of the cdk control of pRb activity. As p21 can associate with E2F subunits, it is possible that these effects are exerted through a complex with E2F. Furthermore, we find that p21 can regulate transcription in vitro. The results suggest that p21 may control E2F activity through a pathway that acts independently of pRb.
Insights
Cyclin-dependent kinase inhibitors like p21 regulate cell proliferation. New findings suggest p21 controls E2F transcription factors independently of pRb, offering novel insights into cell cycle control.
Area of Science:
- Molecular Biology
- Cell Cycle Regulation
- Cancer Research
Background:
- Cyclin-dependent kinase inhibitors (cdkis) control proliferation by inhibiting cyclin-dependent kinases (cdks).
- The p21 gene, a target of p53, is crucial for the p53 response.
- p21 is known to influence cell cycle progression via cdk control of the retinoblastoma protein (pRb).
Purpose of the Study:
- To investigate a novel p21-dependent mechanism regulating E2F transcription factors.
- To explore pathways of E2F regulation independent of cdk/pRb interactions.
Main Methods:
- Investigated the interaction between p21 and E2F subunits.
- Assessed p21's effect on transcription in vitro.
- Analyzed cell cycle regulation pathways.
Main Results:
- Identified a p21-dependent mechanism regulating E2F activity independent of pRb.
- Demonstrated that p21 can associate with E2F subunits.
- Showed that p21 can directly regulate transcription in vitro.
Conclusions:
- p21 may control E2F activity through a mechanism independent of the retinoblastoma protein (pRb).
- p21's interaction with E2F subunits suggests a direct role in transcriptional regulation.
- These findings reveal a new layer of cell cycle control mediated by p21.
Related Concept Videos
Positive Regulator Molecules
Negative Regulator Molecules
Positive Regulator Molecules
Inhibition of Cdk Activity
Abnormal Proliferation
Inhibition of CDK Activity

